Global anorexia and bulimia incidence rose 71% from 1990 to 2023, with an estimated 18.1 million people living with those disorders by 2023. Clinicians report GLP-1 drugs are being misused by people with eating disorders and may worsen symptoms; University of Louisville psychologist Cheri Levinson s